Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9 GBX | -6.74% | -7.69% | +9.22% |
May. 08 | E-Therapeutics Set to Delist from London's AIM | MT |
Apr. 10 | FTSE 100 Closes Up 0.3% as U.S. Uncertainty Boosts Appetite for U.K. Stocks | DJ |
Financials (USD)
Sales 2022 | 0.48 | Sales 2023 | 0.48 | Capitalization | 93.73M |
---|---|---|---|---|---|
Net income 2022 | -8M | Net income 2023 | -8M | EV / Sales 2022 | 306,956,621 x |
Net cash position 2022 | 25.96M | Net cash position 2023 | 31.39M | EV / Sales 2023 | 131,228,741 x |
P/E ratio 2022 |
-20.3
x | P/E ratio 2023 |
-10.5
x | Employees | 34 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.56% |
1 day | -6.74% | ||
1 week | -7.69% | ||
Current month | -8.86% | ||
1 month | -28.00% | ||
3 months | -41.18% | ||
6 months | -21.91% | ||
Current year | +9.22% |
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Mortazavi
CEO | Chief Executive Officer | 53 | 20-01-31 |
Director of Finance/CFO | - | - | |
Alan Whitmore
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Jones
CHM | Chairman | 82 | 15-10-27 |
Director/Board Member | 68 | 20-02-10 | |
Ahmad Mortazavi
CEO | Chief Executive Officer | 53 | 20-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 9 | -6.74% | 2,318,127 |
24-05-07 | 9.65 | +2.66% | 2,411,775 |
24-05-03 | 9.4 | -3.59% | 4,821,033 |
24-05-02 | 9.75 | -0.26% | 615,307 |
24-05-01 | 9.775 | -1.01% | 3,084,089 |
Delayed Quote London S.E., May 08, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+9.22% | 65.81M | |
+23.37% | 47.02B | |
+49.90% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- ETX Stock